Brazil updates trade restriction list after bird flu outbreak
Countrywide suspensions:
Under existing protocols, Brazil stopped issuance of health certificates nationwide for cargoes destined to China, European Union and South Africa.
Countries that announced the suspension of imports from all of Brazil following the outbreak:
Chile, Argentina, Uruguay, Mexico, South Korea, Malaysia and Canada
Regional trade bans:
Singapore: Under health protocols, the ban would apply to products from within a 10-kilometer (6.21 miles) radius.
Japan: Under health protocols, the country has banned products from the town of Montenegro, where the outbreak occurred.
United Arab Emirates: Under health protocols, trade ban would apply to products from the affected area. UAE authorities have not yet made any announcements, Brazil says.
Saudi Arabia: Under health protocols, trade ban would be regional. Based on the country's history, only products from Rio Grande do Sul state would be suspended. Authorities from Saudi Arabia have not yet made any announcements, Brazil says.
Philippines - Under health protocols, ban would apply to products from the affected area. The country's authorities have not yet made any announcements, Brazil says.
Iraq: Brazil stopped issuing health certificates for products from the area. The country's authorities have not yet made any announcements, Brazil says.
Bahrain: Authorities banned imports from Rio Grande do Sul state
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arabian Business
9 hours ago
- Arabian Business
Abu Dhabi launches newborn genetic screening programme to detect 815 childhood conditions
The Department of Health – Abu Dhabi (DoH) has launched the Newborn Genetic Screening Programme, one of the most comprehensive of its kind globally, offering whole genome sequencing to screen for more than 815 treatable childhood genetic conditions. The initiative, launched in alignment with the Emirati Genome Council's vision for personalised and precision healthcare, marks a step towards genomics-driven medicine in the UAE. It enables early detection, tailored interventions, and improved health outcomes for newborns. In its first phase, the programme has been introduced at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42, as a voluntary option. It is set to expand across all maternity hospitals in the emirate to cover UAE nationals and children of Emirati mothers. By testing cord blood samples at birth with parental consent, the programme screens for metabolic disorders, immunodeficiencies, hematologic conditions, and rare diseases such as spinal muscular atrophy, which can be treated with gene therapy. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Healthcare begins long before symptoms appear, and today, empowered by science and technology, we can act earlier than ever before. This programme reflects Abu Dhabi's commitment to leveraging innovation to serve our community, starting from the first days of life. Through early detection, personalised care, and strategic foresight, we are building a future of healthier generations and reinforcing Abu Dhabi's position as a global leader in proactive, precision healthcare.' Dr. Mohamed Al Ameri, Acting Director of Genome and Biobank Division, Department of Health – Abu Dhabi, said: 'As we work to integrate genomics into our preventative healthcare infrastructure, we aim to expand this initiative to all maternity hospitals in the emirate, demonstrating how genomics can reshape healthcare, shifting from a one-size-fits-all model to a precise, proactive, and personalised approach that improves patient outcomes.' To support the rollout, DoH held workshops with stakeholders to review the gene panel and patient journey, and trained 16 paediatricians and neonatologists on genetic counselling practices. Results are reported within 21 days, with genetic counselling and referrals provided if actionable findings are identified. The Newborn Genetic Screening Programme builds on initiatives under the Emirati Genome Programme, including premarital screening, and is part of a broader strategy to integrate genomics into family health to reduce the prevalence of genetic diseases and support informed decision-making.
Zawya
13 hours ago
- Zawya
Cleveland Clinic Abu Dhabi introduces breakthrough stroke treatment
Cleveland Clinic Abu Dhabi has performed the region's first procedure using the Artisse Intrasaccular Flow Modulator, a pioneering medical implant for treating wide-necked brain aneurysms. Designated by the Department of Health – Abu Dhabi as a Centre of Excellence for stroke, the hospital is the first in the Middle East and North Africa to adopt the technology. The minimally invasive procedure involves inserting a catheter through a blood vessel to deploy a mesh device that seals the aneurysm, preventing rupture and reducing the risk of stroke. The first patient treated with the device at the hospital showed successful aneurysm closure after three months, underscoring the technology's potential for safer and more effective outcomes. Fayeza Al Yafie, Executive Director of Healthcare Quality at the Department of Health – Abu Dhabi, said the milestone reflects the emirate's commitment to innovation and advanced patient care. Khalil Zahra, Staff Physician in Neurosurgery at Cleveland Clinic Abu Dhabi, said the new approach enhances treatment for complex aneurysms while reducing the need for invasive surgery. Since launching the UAE's first multi-organ transplant programme in 2017, Cleveland Clinic Abu Dhabi has become a leading referral centre for advanced care. The adoption of this device further strengthens its role as a hub for neurological innovation in the region.
Khaleej Times
15 hours ago
- Khaleej Times
Dubai man undergoes complex awake brain surgery at NMC, recovers with renewed hope
What initially appeared to be fatigue gradually progressed to more serious neurological symptoms, prompting him to seek help at NMC's emergency department In a remarkable demonstration of advanced medical care and patient resilience, NMC Specialty Hospital, Al Nahda, Dubai, has successfully performed a high-precision awake brain surgery on a Dubai-based hotel employee, enabling his recovery from a complex brain tumour while preserving vital motor functions. Raymundo Omega, a long-time UAE resident and hospitality professional, began experiencing unexplained health concerns last year. What initially appeared to be fatigue gradually progressed to more serious neurological symptoms, prompting him to seek help at NMC's emergency department. Advanced diagnostic imaging revealed a lesion deep within the eloquent cortex of the right frontal lobe which a part of the brain that controls voluntary movement. While the imaging suggested it could be something serious, a tissue sample was needed to confirm exactly what it was and what the best form of treatment would be. Dr Sharath Kumar Maila, specialist neurosurgeon at NMC Specialty Hospital, Al Nahda, took on the complex case. "The tumour's location made surgery particularly challenging,' he explained. 'Our initial goal was to confirm the diagnosis through a biopsy. It was a very delicate process, as the lesion affected the motor cortex in areas that send signals to his muscles to move and areas which plan and coordinate complex movements before they are carried out (Brodmann areas 4 and 6). We had to meticulously plan the biopsy to avoid causing neurological issues. Using a robotic arm guided by neuronavigation, we safely obtained the tissue sample without any neurologic deficits.' The biopsy confirmed the tumour was a high-grade glioma and highly aggressive, so the goal was to remove as much of it as possible while keeping movement and muscle control intact. Given the tumour's location, an awake craniotomy or brain surgery while the patient remains awake was deemed the most effective and safest approach. During surgery, Omega remained conscious during critical phases, allowing surgeons to monitor real-time motor responses and map functional brain areas. 'We used a combination of real-time intraoperative ultrasound, fluorescence guidance, and neuronavigation, all working in tandem to guide the procedure,' Dr Sharath noted. The team achieved a significant tumour resection while preserving the patient's movement and functionality. Omega was able to walk immediately after surgery and was discharged in stable condition after four days in hospital. 'This was my first surgery, and I was initially very nervous,' said Omega. 'But the team at NMC Specialty Hospital, Al Nahda gave me the confidence to move forward. Their care and support were truly exceptional.' Omega is now undergoing postoperative therapy as part of a comprehensive, multidisciplinary care plan. His case underscores the importance of early intervention, technological innovation, and collaborative care in neurosurgical outcomes. 'When it comes to neurological tumours, timing is everything,' emphasised Dr. Sharath. 'Early diagnosis and timely surgical intervention can significantly influence recovery and long-term outcomes. At NMC, we remain committed to delivering patient-focused care using the latest advancements in medical technology.'
